| Literature DB >> 34394258 |
Samina Ismail1, Muhammad Sohaib1, Fatima Farrukh2.
Abstract
BACKGROUND: In developing countries, more than half of the anesthesia-related maternal deaths are related to spinal hypotension.Entities:
Keywords: Cesarean delivery; Hypotension; Spinal anesthesia; Vasopressors
Mesh:
Substances:
Year: 2020 PMID: 34394258 PMCID: PMC8351839 DOI: 10.4314/ahs.v20i4.50
Source DB: PubMed Journal: Afr Health Sci ISSN: 1680-6905 Impact factor: 0.927
Figure 1Methods routinely used to prevent spinal induced hypotension (n=156)
Choice of vasopressors for the prevention and treatment of Spinal-induced hypotension
| Choice of vasopressors | Prevention | Treatment |
| Ephedrine | 8(5.1) | 13 (8.3) |
| Phenylephrine | 52(33.1) | 89(57) |
| Phenylephrine and ephedrine | 2(1.3) | 1(0.6) |
| Either phenylephrine or | 31(19.9) | 41(26.3) |
| Epinephrine | 1(0.6) | 7 (4.4) |
| Norepinephrine | 1(0.6) | 5(3.2) |
Data are numbers (%)
Figure 2Route of administration of vasopressors for the prevention and treatment of spinal-induced hypotension
Effect of level of anesthesiologists (attending vs. trainee), clinical responsibility to obstetric anesthesia and type of practice (academic vs. private vs. both) on methods and types of fluids for prevention of spinal induced hypotension
| Number | Level | P-Value | Clinical responsibility | P-Value | Type of practice | P-Value | |||||
| Attending | Training | ≥30% | <30% | Academic | Private | Both | |||||
| Fluid | 51 | 21(26.9%) | 30(38.5%) | 0.125 | 19(33.9%) | 32(32%) | 0.805 | 29(29.6%) | 6(46.2%) | 16(35.6%) | 0.435 |
| Fluid | 29 | 16(20.5%) | 13(16.7%) | 0.537 | 14(25%) | 15(15%) | 0.124 | 23(23.5%) | 3(23.1%) | 3(6.7%) | 0.051 |
| Fluid coloading | 30 | 16(20.5%) | 14(17.9%) | 0.685 | 5(8.9%) | 25(25%) | 0.015 | 20(20.4%) | 1(7.7%) | 9(20%) | 0.544 |
| Fluid coloading | 35 | 23(29.5%) | 12(15.4%) | 0.035 | 18(32.1%) | 17(17%) | 0.03 | 20(20.4%) | 2(15.4%) | 13(28.9%) | 0.432 |
| None of the | 11 | 2(2.6%) | 9(11.5%) | 0.029 | 0(0%) | 11(11%) | 0.008 | 6(6.1%) | 1(7.7%) | 4(8.9%) | 0.832 |
| Crystalloids | 85 | 43(55.1%) | 42(56%) | 0.914 | 28(50%) | 57(58.8%) | 0.293 | 61(63.5%) | 7(53.8%) | 17(38.6%) | |
| Colloids only | 16 | 9(11.5%) | 7(9.3%) | 0.656 | 7(12.5%) | 9(9.3%) | 0.53 | 7(7.3%) | 1(7.7%) | 8(18.2%) | 0.14 |
| Both | 45 | 25(32.1%) | 20(26.7%) | 0.465 | 21(37.5%) | 24(24.7%) | 0.095 | 25(26%) | 4(30.8%) | 16(36.4%) | 0.458 |
| None of the | 7 | 1(1.3%) | 6(8%) | 0.06 | 0(0%) | 7(7.2%) | 0.048 | 3(3.1%) | 1(7.7%) | 3(6.8%) | 0.533 |
Effect of level of anesthesiologists (attending vs. trainee), clinical responsibility to obstetric anesthesia and type of practice (academic vs. private vs. both) on the routine use of vasopressors for prophylaxis and treatment
| Number | Level | P-Value | Clinical responsibility | P-Value | Type of practice | P-Value | |||||
| Attending | Training | ≥30% | <30% | Academic | Private | Both | |||||
| Ephedrine | 8 | 5(6.4%) | 3(3.8%) | 0.468 | 4(7.1%) | 4(4%) | 0.459 | 2(2%) | 2(15.4%) | 4(8.9%) | |
| Phenylephrine | 52 | 24(30.8%) | 28(35.9%) | 0.497 | 18(32.1%) | 34(34%) | 0.813 | 37(37.8%) | 3(23.1%) | 12(26.7%) | 0.305 |
| Phenylephrine and | 2 | 2(2.6%) | 0(0%) | 0.497 | 1(1.8%) | 1(1%) | 0.999 | 1(1%) | 1(7.7%) | 0(0%) | 0.088 |
| Either phenylephrine or | 31 | 17(21.8%) | 14(17.9%) | 0.548 | 15(26.8%) | 16(16%) | 0.105 | 24(24.5%) | 3(23.1%) | 4(8.9%) | 0.09 |
| Epinephrine | 1 | 0(0%) | 1(1.3%) | 0.999 | 0(0%) | 1(1%) | 0.999 | 1(1%) | 0 | 0 | 0.742 |
| Norepinephrine | 1 | 1(1.3%) | 0(0%) | 0.999 | 0(0%) | 1(1%) | 0.999 | 1(1%) | 0 | 0 | 0.742 |
| Do not use prophylaxis | 61 | 29(37.2%) | 32(41%) | 0.623 | 18(32.1%) | 43(43%) | 0.183 | 32(32.7%) | 4(30.8%) | 25(55.6%) | |
| Ephedrine | 13 | 9(11.5%) | 4(5.2%) | 0.154 | 7(12.5%) | 6(6.1%) | 0.227 | 8(8.2%) | 3(23.1%) | 2(4.4%) | 0.102 |
| Phenylephrine | 89 | 40(51.3%) | 49(63.6%) | 0.12 | 26(46.4%) | 63(63.6%) | 0.037 | 61(62.9%) | 3(23.1%) | 25(55.6%) | |
| Phenylephrine and | 1 | 1(1.3%) | 0(0%) | 0.999 | 1(1.8%) | 0(0%) | 0.361 | 1(1%) | 0 | 0 | 0.74 |
| Either phenylephrine or | 41 | 26(33.3%) | 15(19.5%) | 0.051 | 19(33.9%) | 22(22.2%) | 0.112 | 23(23.7%) | 5(38.5%) | 13(28.9%) | 0.478 |
| Epinephrine | 3 | 0(%) | 3(3.9%) | 0.12 | 2(3.6%) | 1(1%) | 0.266 | 2(2.1%) | 0 | 0 | 0.868 |
| Norepinephrine | 1 | 1(1.3%) | 0(0%) | 0.999 | 0(0%) | 1(1%) | 0.999 | 1(1%) | 0 | 0 | 0.74 |
| Non and Other | 7 | 1(1.3%) | 6(7.8%) | 0.063 | 1(1.8%) | 6(6.1%) | 0.423 | 1(1%) | 2(15.4%) | 4(8.9%) | |